A_review_of_californium-252_neutron_brachytherapy_for_cervical_cancer._Since_1976_a_clinical_trial_has_been_conducted_to_test_the_feasibility,_the_potential,_and_to_develop_methods_for_using_the_neutron-emitting_radioactive_isotope,_californium-252_(Cf-252),_for_the_treatment_of_cervical_cancer._A_total_of_218_patients_were_treated_in_the_initial_study_period_from_1976_until_1983._The_trials_initially_treated_advanced_(Stages_III_and_IV)_cervical_cancer_patients_using_different_doses_and_schedules;_they_were_extended_to_include_unfavorable_presentations_of_Stages_I_and_II_because_of_favorable_results_in_the_initial_trials._The_authors_began_to_treat_patients_with_Stage_IB_bulky_or_barrel-shaped_tumors_and_the_majority_were_treated_with_both_radiation_and_hysterectomy._Actuarial_survival_was_determined_for_Stage_IB_disease_and_was_87%_at_5_years_and_82%_at_10_years._For_those_tested_with_preoperative_radiation_it_was_92%_at_5_and_87%_at_10_years._For_Stage_II,_it_was_62%_5_years_and_61%_at_10._Survival_5_years_after_combined_radiation_and_surgical_therapy_for_Stage_II_disease_was_68%._For_Stage_III,_it_was_33%_at_5_years_and_25%_at_10._However,_5-year_survival_using_the_early_neutron_implant_was_46%_versus_approximately_19%_for_delayed_Cf-252_or_cesium_137._Different_schedules_and_sequences_of_neutrons_and_photons_greatly_altered_outcome._Neutron_treatment_before_external_photon_therapy_was_better_for_all_stages_of_disease._Only_about_5%_of_all_patients_developed_complications_after_neutron_therapy._No_hematologic_or_mesenchymal_second_tumors_were_observed._Neutron_brachytherapy_was_found_to_be_very_effective_for_producing_rapid_response_and_greatly_improved_local_control_of_bulky,_barrel,_or_advanced_cervical_cancers._The_clinical_trial_identified_and_evolved_schedules,_doses,_doses_per_session,_and_developed_methods_different_from_standard_photon_therapy_but_highly_effective_for_local_control_and_cure_of_cervical_cancers_of_all_stages._Clinical_and_radiobiologic_understanding_for_the_use_of_neutron_therapy_was_greatly_advanced_by_this_trial._Future_trials_will_focus_on_patients_with_advanced_disease_and_will_require_evaluation_of_adjuvant_chemotherapy_studies_and_neutron-enhancing_chemicals.